Skip to main content
letter
. 2023 Mar 24;13(1):44. doi: 10.1038/s41408-023-00813-x

Fig. 1. Clinical outcomes of patients with MRD-positive B-ALL after CD19/CD22 bispecific CAR-T cells.

Fig. 1

The bar chart shows the clinical response and follow-up of patients during CAR-T therapy. Each bar represents an individual patient and the study number. The different colors represent different disease status.